438 related articles for article (PubMed ID: 3708604)
41. Sinemet CR for Parkinson's disease.
Med Lett Drugs Ther; 1991 Oct; 33(854):92-3. PubMed ID: 1895993
[No Abstract] [Full Text] [Related]
42. Drug adherence in Parkinson's disease.
Leopold NA; Polansky M; Hurka MR
Mov Disord; 2004 May; 19(5):513-7. PubMed ID: 15133814
[TBL] [Abstract][Full Text] [Related]
43. Results of long-term treatment with controlled-release levodopa/carbidopa (Sinemet CR).
Cedarbaum JM; Silvestri M; Clark M; Toy L; Harts A; Green-Parsons A; McDowell FH
J Neural Transm Park Dis Dement Sect; 1990; 2(3):205-13. PubMed ID: 2257060
[TBL] [Abstract][Full Text] [Related]
44. Augmentation of artistic productivity in Parkinson's disease.
Walker RH; Warwick R; Cercy SP
Mov Disord; 2006 Feb; 21(2):285-6. PubMed ID: 16261619
[No Abstract] [Full Text] [Related]
45. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
[TBL] [Abstract][Full Text] [Related]
46. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
Greene P; Cote L; Fahn S
Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
[No Abstract] [Full Text] [Related]
47. New concepts in the treatment of Parkinson's disease.
Ahlskog JE; Wilkinson JM
Am Fam Physician; 1990 Feb; 41(2):574-84. PubMed ID: 1967895
[TBL] [Abstract][Full Text] [Related]
48. Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations.
Jankovic J; Schwartz K; Vander Linden C
Mov Disord; 1989; 4(4):303-9. PubMed ID: 2682215
[TBL] [Abstract][Full Text] [Related]
49. Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease.
Ahlskog JE; Muenter MD; McManis PG; Bell GN; Bailey PA
Mayo Clin Proc; 1988 Sep; 63(9):876-86. PubMed ID: 3045435
[TBL] [Abstract][Full Text] [Related]
50. Off-period screaming accompanying motor fluctuations in Parkinson's disease.
Steiger MJ; Quinn NP; Toone B; Marsden CD
Mov Disord; 1991; 6(1):89-90. PubMed ID: 2005932
[No Abstract] [Full Text] [Related]
51. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
Lombardo L; De la Garza R
Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
[TBL] [Abstract][Full Text] [Related]
52. Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studies.
LeWitt PA; Nelson MV; Berchou RC; Galloway MP; Kesaree N; Kareti D; Schlick P
Neurology; 1989 Nov; 39(11 Suppl 2):45-53; discussion 59. PubMed ID: 2685650
[TBL] [Abstract][Full Text] [Related]
53. Unforeseen beneficial effects of controlled-release levodopa-carbidopa (Sinemet CR).
Makela EH; Cutlip WD
J Neuropsychiatry Clin Neurosci; 1992; 4(2):234-5. PubMed ID: 1627988
[No Abstract] [Full Text] [Related]
54. New drugs for Parkinson's disease.
Hodges LC; Rapp CG
J Neurosci Nurs; 1990 Aug; 22(4):254-7. PubMed ID: 2144560
[TBL] [Abstract][Full Text] [Related]
55. Perioperative medication withholding in patients with Parkinson's disease: a retrospective electronic health records review.
Fagerlund K; Anderson LC; Gurvich O
Am J Nurs; 2013 Jan; 113(1):26-35; quiz 36. PubMed ID: 23247677
[TBL] [Abstract][Full Text] [Related]
56. IPX066: a novel carbidopa-levodopa extended-release formulation.
Hauser RA
Expert Rev Neurother; 2012 Feb; 12(2):133-40. PubMed ID: 22288668
[TBL] [Abstract][Full Text] [Related]
57. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L
Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
[TBL] [Abstract][Full Text] [Related]
58. Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa.
Metman LV; Hoff J; Mouradian MM; Chase TN
Mov Disord; 1994 Jul; 9(4):463-5. PubMed ID: 7969216
[TBL] [Abstract][Full Text] [Related]
59. Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet).
Goetz CG; Tanner CM; Klawans HL; Shannon KM; Carroll VS
Neurology; 1987 May; 37(5):875-8. PubMed ID: 3574696
[TBL] [Abstract][Full Text] [Related]
60. Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease.
Meppelink AM; Nyman R; van Laar T; Drent M; Prins T; Leenders KL
Mov Disord; 2011 Feb; 26(2):331-4. PubMed ID: 20960486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
